High drug prices are not justified by industry’s spending on research and development
Angelis, Aris
; Polyakov, Roman; Wouters, Olivier J.; Torreele, Els; and McKee, Martin
High drug prices are not justified by industry’s spending on research and development
BMJ, 380 (8371): e071710.
ISSN 1756-1833
; Polyakov, Roman; Wouters, Olivier J.; Torreele, Els; and McKee, Martin
High drug prices are not justified by industry’s spending on research and development
BMJ, 380 (8371): e071710.
ISSN 1756-1833
Aris Angelis and colleagues argue that by refocusing their spending drug companies could provide more innovative drugs at affordable prices
-
picture_as_pdf -
subject - Accepted Version
Downloads